Crossmark

Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: the first comprehensive report from the Middle East

Crossref DOI link: https://doi.org/10.1186/s12885-021-08074-2

Published Online: 2021-04-01

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Akhtar, Saad https://orcid.org/0000-0002-4294-0944
Rauf, M. Shahzad

Khafaga, Yasser

Al-Kofide, Amani

Elhassan, Tusneem Ahmed M.

Elshenawy, Mahmoud A.

Nadri, Juzer

Mushtaq, Ali Hassan

Bakshi, Nasir

Shamayel, Mohammed

Al-Sweedan, Suleiman

Sarwar, Sohail

Maghfoor, Irfan
License Information

Text and Data Mining valid from 2021-04-01

Version of Record valid from 2021-04-01
More Information

Article History

Received: 24 March 2020

Accepted: 21 March 2021

First Online: 1 April 2021

Declarations

:

: Approved by Institutional “Research Advisory Council (RAC)”. King Faisal Specialist Hospital & Research Center, Riyadh, Kingdom of Saudi Arabia. RAC project # 2021–048 lymphoma database. Waiver of signed consent as per RAC (no individual patient identified data / no pictures / verbal consent documented on paper or electronic chart). This waiver of signed consent was for participation in the database collection study and subsequent publications as per RAC guidelines.

: Not applicable.

: None.

Document is current

Any future updates will be listed below